Molecular Formula: C₂₀H₃₃N₅O₉
Sequence: Lys-Glu-Asp-Pro (KEDP)
Molecular Weight: 487.5 g/mol
PubChem CID: 9848296
Purity: >99% | Vial Size: 20mg | Storage: -20°C, protect from light
 
Product Overview
Prostamax represents breakthrough Khavinson bioregulator technology with profound DNA condensation effects and cellular function enhancement. This synthetic tetrapeptide demonstrates tissue-specific prostate benefits while providing broad anti-aging effects through epigenetic DNA regulation. Unlike conventional treatments, Prostamax works at the genetic level by decondensing heterochromatin, restoring youthful genetic profiles to aging cells.
Revolutionary DNA Decondensation Mechanism
Prostamax functions through unique epigenetic mechanisms reversing age-related DNA condensation. The peptide targets densely packed heterochromatin, opening previously inaccessible genetic material for transcription. This decondensation is crucial because DNA condensation drives cellular senescence and apoptosis - a fundamental aging mechanism.
Primary Research Applications
Chronic Prostatitis Research
Exceptional efficacy against chronic abacterial prostatitis (CAP) affecting 16% of men. Rat studies show 15-day treatment reduces prostate swelling, vascular congestion, and immune infiltration while decreasing scarring and preventing pathological remodeling leading to cancer.
Anti-Aging & Longevity Studies
Cell culture research confirms ability to restore youthful genetic profiles through heterochromatin decondensation. Increases cellular proliferation, reduces apoptosis, improves protein expression. Naturally found in long-lived species like African mole rats but absent in short-lived species.
Immune System Research
Significantly affects lymphocyte function by increasing ribosome expression and opening chromatin for enhanced gene accessibility. Optimizes immune cell function from mRNA translation to protein synthesis, improving responses and reducing inflammation.
Cancer Prevention Studies
May reduce cancer risk by eliminating chronic inflammation leading to pathological hypertrophy/hyperplasia. Anti-inflammatory effects with normalized cellular growth provide protective mechanisms against malignant transformation.
Mechanism of Action
Heterochromatin Decondensation: Opens DNA regions for gene expression
Ribosome Enhancement: Increases protein synthesis in lymphocytes
mRNA Accessibility: Improves gene transcription capabilities
Anti-inflammatory Action: Reduces cytokines and immune infiltration
Cellular Repair: Promotes normalized growth and differentiation
Research Advantages
Epigenetic Action: Direct DNA interaction bypassing receptor limitations
Tissue-Specific Effects: Primary prostate targeting with systemic benefits
Rapid Efficacy: Significant results within 15-day protocols
Multi-System Impact: Benefits prostate, immune, cardiovascular systems
Natural Longevity Connection: Found in long-lived species
Cancer Protective: Malignancy prevention through normalized function
Khavinson Bioregulator Heritage
Developed by Professor Vladimir Khavinson representing 40+ years peptide bioregulator research. His work resulted in 6 pharmaceutical approvals, 64 supplements, 196 patents, 775 publications, establishing scientific foundation for peptide-based anti-aging interventions.
Quality Specifications
Every batch undergoes comprehensive QC:
HPLC purity analysis (>99%)
Mass spectrometry verification (487.5 g/mol)
Amino acid sequence confirmation (KEDP)
Endotoxin testing (<1.0 EU/mg)
USP sterility standards
Certificate of Analysis provided
Storage & Reconstitution
Store lyophilized at -20°C in sealed vials. Protect from light/humidity. Reconstitute with bacteriostatic water before use. Use within 24 hours or store -80°C short-term. Avoid freeze-thaw cycles.
Research Protocol Applications
Direct tissue administration for prostate studies
Systemic injection for anti-aging research
Chronic dosing for longevity investigations
Combination studies with other bioregulators
Immune function enhancement protocols
Cardiovascular protection research
Clinical Research Timeline
Days 1-15: Inflammation reduction, improved urinary function
Weeks 2-4: Increased cellular proliferation, decreased apoptosis
Month 1-3: DNA decondensation effects, improved protein synthesis
Long-term: Sustained anti-aging benefits, reduced cancer risk
Research Applications Summary
Chronic prostatitis and urological research
Anti-aging and longevity studies
Immune system optimization
Epigenetic regulation investigations
Cancer prevention studies
Cardiovascular protection research
DNA condensation mechanism studies
Cellular senescence research
Age-related inflammation research
Safety Profile
Excellent safety profile with minimal adverse effects. Natural occurrence in long-lived species and tissue-specific targeting contribute to favorable safety characteristics versus conventional interventions.
Regulatory Compliance
Manufactured under strict GMP conditions exclusively for research. Not approved for human consumption or therapeutic use. Researchers must follow institutional guidelines and obtain ethics approvals.
Research Use Only: Not for human/veterinary therapeutics. Handle per laboratory safety and institutional research guidelines.